These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19552750)

  • 1. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus.
    Al Mazroui NR; Kamal MM; Ghabash NM; Yacout TA; Kole PL; McElnay JC
    Br J Clin Pharmacol; 2009 May; 67(5):547-57. PubMed ID: 19552750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a 36-month pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients.
    Neto PR; Marusic S; de Lyra Júnior DP; Pilger D; Cruciol-Souza JM; Gaeti WP; Cuman RK
    J Pharm Pharm Sci; 2011; 14(2):249-63. PubMed ID: 21733413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.
    Clifford RM; Davis WA; Batty KT; Davis TM;
    Diabetes Care; 2005 Apr; 28(4):771-6. PubMed ID: 15793171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial.
    Ladhani NN; Majumdar SR; Johnson JA; Tsuyuki RT; Lewanczuk RZ; Spooner R; Simpson SH
    Diabet Med; 2012 Nov; 29(11):1433-9. PubMed ID: 22486226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial.
    Wishah RA; Al-Khawaldeh OA; Albsoul AM
    Diabetes Metab Syndr; 2015; 9(4):271-6. PubMed ID: 25301007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.
    Pousinho S; Morgado M; Falcão A; Alves G
    J Manag Care Spec Pharm; 2016 May; 22(5):493-515. PubMed ID: 27123912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.
    Mehuys E; Van Bortel L; De Bolle L; Van Tongelen I; Annemans L; Remon JP; Giri M
    J Clin Pharm Ther; 2011 Oct; 36(5):602-13. PubMed ID: 21143256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical care of elderly patients with poorly controlled type 2 diabetes mellitus: a randomized controlled trial.
    Chen JH; Ou HT; Lin TC; Lai EC; Kao YH
    Int J Clin Pharm; 2016 Feb; 38(1):88-95. PubMed ID: 26499503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.
    Davies MJ; Heller S; Skinner TC; Campbell MJ; Carey ME; Cradock S; Dallosso HM; Daly H; Doherty Y; Eaton S; Fox C; Oliver L; Rantell K; Rayman G; Khunti K;
    BMJ; 2008 Mar; 336(7642):491-5. PubMed ID: 18276664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia.
    Lim PC; Lim K; Embee ZC; Hassali MA; Thiagarajan A; Khan TM
    Pak J Pharm Sci; 2016 Mar; 29(2):595-601. PubMed ID: 27087103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
    Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
    J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Pharmacist-Managed Diabetes Program in a Primary Care Setting Within an Integrated Health Care System.
    Benedict AW; Spence MM; Sie JL; Chin HA; Ngo CD; Salmingo JF; Vidaurreta AT; Rashid N
    J Manag Care Spec Pharm; 2018 Feb; 24(2):114-122. PubMed ID: 29384029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist led intervention towards management of type 2 diabetes mellitus and assessment of patient satisfaction of care - A prospective, randomized controlled study.
    Simon MA; Raja BY; Varughese PC; Daniel LM; Sowjanya K; S KJ; S S; Rathinam KK; Kumar J P
    Diabetes Metab Syndr; 2021; 15(5):102208. PubMed ID: 34298274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain.
    Fornos JA; Andrés NF; Andrés JC; Guerra MM; Egea B
    Pharm World Sci; 2006 Apr; 28(2):65-72. PubMed ID: 16791717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study.
    Ali M; Schifano F; Robinson P; Phillips G; Doherty L; Melnick P; Laming L; Sinclair A; Dhillon S
    Diabet Med; 2012 Sep; 29(9):e326-33. PubMed ID: 22672148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication Management Program: Adherence, Disease-related Knowledge, Health-related Quality of Life, and Glycemic Control for Type 2 Diabetes Mellitus.
    Nazir SUR; Hassali MA; Saleem F; Haque N
    Altern Ther Health Med; 2020 Jul; 26(S2):4-10. PubMed ID: 31634877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.
    Suppapitiporn S; Chindavijak B; Onsanit S
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S134-41. PubMed ID: 16623018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.